Multispecialty - Abbvie

Status:

Enrolling

ClinicalTrials.gov:

NCT05843643

A Phase 3 Program to Evaluate the Safety and Efficacy of Upadacitinib in Subjects with Moderately to Severely Active SLE

Phase

Phase 3

Condition

Systemic Lupus Erythematosus